Loading...
Fluoxetine in Progressive Multiple Sclerosis (FLUOX-PMS): study protocol for a randomized controlled trial
BACKGROUND: Currently available disease-modifying treatments acting by modifying the immune response are ineffective in progressive multiple sclerosis (MS), which is caused by a widespread axonal degeneration. Mechanisms suspected to be involved in this widespread axonal degeneration are reduced axo...
Na minha lista:
| Main Authors: | , , , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
BioMed Central
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3931920/ https://ncbi.nlm.nih.gov/pubmed/24460863 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1745-6215-15-37 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|